...
首页> 外文期刊>ACS Omega >Plant-Derived Tandem Drug/Mesoporous Silicon Microcarrier Structures for Anti-Inflammatory Therapy
【24h】

Plant-Derived Tandem Drug/Mesoporous Silicon Microcarrier Structures for Anti-Inflammatory Therapy

机译:用于抗炎治疗的植物来源的串联药物/中孔硅微载体结构

获取原文

摘要

The properties of nanostructured plant-derived porous silicon (pSi) microparticles as potential candidates to increase the bioavailability of plant extracts possessing anti-inflammatory activity are described in this work. pSi drug carriers were fabricated using an eco-friendly route from the silicon accumulator plant bamboo (tabasheer) powder by magnesiothermic reduction of plant-derived silica and loaded with ethanolic extracts of Equisetum arvense, another silicon accumulator plant rich in polyphenolic compounds. The anti-inflammatory properties of the active therapeutics present in this extract were measured by sensitive luciferase reporter assays; this active extract was subsequently loaded and released from the pSi matrix, with a clear inhibition of the activity of the inflammatory signaling protein NF-κB over a period of hours in a sustained manner. Our results showed that after loading the extracts of E. arvense into pSi microparticles derived from tabasheer, enhanced anti-inflammatory activity was observed owing to enhanced solubility of the extract.
机译:这项工作描述了纳米结构的植物来源的多孔硅(pSi)微粒作为潜在候选物的特性,这些微粒可以增加具有抗炎活性的植物提取物的生物利用度。 pSi药物载体是采用生态友好的方法,通过硅热蓄积植物竹(tabasheer)粉末通过镁热还原植物衍生的二氧化硅而制成的,并装载了木贼木贼的乙醇提取物,该植物是另一种富含多酚化合物的硅蓄积植物。通过敏感的萤光素酶报告基因测定法测定了该提取物中存在的活性治疗剂的抗炎特性;该活性提取物随后被装载并从pSi基质中释放出来,并在数小时内持续抑制炎症信号蛋白NF-κB的活性。我们的结果表明,将欧文肠球菌提取物加载到来源于塔巴沙虫的pSi微粒中后,由于提取物的溶解度提高,观察到了增强的抗炎活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号